| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.0086 | 1 |